Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy. Read more about Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy.
Safety and immunogenicity of Fc-EDA, a recombinant ectodysplasin A1 replacement protein, in human subjects. Read more about Safety and immunogenicity of Fc-EDA, a recombinant ectodysplasin A1 replacement protein, in human subjects.
Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D. Read more about Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D.
Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro. Read more about Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro.
Medicine information exchange networks among healthcare professionals and prescribing in geriatric medicine wards. Read more about Medicine information exchange networks among healthcare professionals and prescribing in geriatric medicine wards.
A comparison of medical and pharmacy students' knowledge and skills of pharmacology and pharmacotherapy. Read more about A comparison of medical and pharmacy students' knowledge and skills of pharmacology and pharmacotherapy.
Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factors. Read more about Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factors.
Dose-independent kinetics with low level exposure to nicotine and cotinine. Read more about Dose-independent kinetics with low level exposure to nicotine and cotinine.
Effect of nicotine on cytochrome P450 1A2 activity. Read more about Effect of nicotine on cytochrome P450 1A2 activity.
Gentamicin pharmacokinetics in old age and frailty. Read more about Gentamicin pharmacokinetics in old age and frailty.
